Federal inspectors found the pattern across multiple diabetic residents at Mirage Post Acute during a January 17 inspection. In one case, a resident received 20 consecutive insulin shots in the left lower abdomen quadrant over two months. Another resident got injections in the same arm location four times in a row.
The facility's own policy requires rotating injection sites "preferably within the same general area" to prevent pain, redness, irritation, and lipodystrophy — a condition where skin thickens or develops pits at injection sites.
Resident 66, who has severe cognitive impairment and requires maximum assistance with daily activities, received Humalog insulin shots exclusively in the left lower abdomen from November through January. Records show 20 injections between November 19 and January 10, all in the same quadrant.
The resident's physician had specifically ordered staff to "rotate injection sites" when prescribing the diabetes medication on December 28. Licensed Vocational Nurse 9 confirmed the violations during interviews with inspectors, stating injection sites "should have been rotated as ordered by the physician to prevent pain, redness, irritation, lipodystrophy, and denting of the resident's skin."
Resident 64, who has Type 2 diabetes and receives feedings through a gastrostomy tube, experienced similar problems with both short-acting and long-acting insulin. NPH insulin shots were given in the same abdomen quadrant on consecutive days in November and December. Regular insulin injections hit the same right upper abdomen area repeatedly in December and January.
The facility provided manufacturer guidelines that explicitly warn against this practice. Humulin documentation states: "Change (rotated) where to inject the insulin to help prevent lipodystrophy from happening. Do not inject into the exact spot for each injection."
Another manufacturer's guide warns of "injection site reactions such as redness, swelling and itching" and lists lipodystrophy as a known adverse reaction.
Director of Nursing staff acknowledged the violations posed real risks. During a January 17 interview, the nursing director stated injection sites should be rotated "to prevent complications such as bruising, and lipodystrophy." Licensed nurses confirmed the same sites were used repeatedly despite clear orders to rotate.
The problems extended beyond insulin to other injectable medications. Resident 73, who has diabetes and takes blood thinner injections to prevent clots, received heparin shots in the same abdomen quadrants on consecutive days. The heparin manufacturer specifically warns that "a different side should be used for each injection to prevent the development of massive hematoma."
Five residents total were affected by the injection site failures. Records show the pattern persisted across different types of insulin and time periods, suggesting systemic problems rather than isolated incidents.
In a separate violation, inspectors found a resident's specialized pressure-relief mattress turned off when it should have been running continuously. Resident 66, who has pressure ulcers on the left buttock, was found "sunk in the bed" with the low air loss mattress machine showing only a dim orange light instead of the green indicators that signal proper operation.
Treatment Nurse 1 could not determine how long the machine had been off. When turned on, the setting was incorrect for the resident's body mass index. The resident weighs 212 pounds with a BMI of 28.7, requiring a setting of 2, but the machine was set to 3.
The facility's policy states the mattress should "always leave unit turned on when in use" and that "pressure adjustments may be made by staff in accordance with resident condition and need." The manufacturer's guidelines indicate the powered modes are "intended for active wound treatment" of pressure ulcers.
The nursing director told inspectors the mattress "should not have been turned off unless the resident was not in bed" and acknowledged it placed the resident "at risk for worsening of pressure ulcers."
Inspectors also documented basic hygiene failures. Resident 115, who requires extensive assistance with personal care, had long fingernails with black substance underneath them during multiple observations. His assigned nursing assistant acknowledged the nails "were long and had dirt underneath" and needed trimming.
The assistant warned that untrimmed nails could lead Resident 115 to "accidentally scratch himself and can cause an infection." The facility's nail care policy requires "daily cleaning and regular trimming" to prevent residents from "accidentally scratching and injuring his or her skin."
Additional safety hazards were found throughout the facility. Medications were left at resident bedsides where they could be accidentally ingested. Call lights had exposed or frayed wiring that could cause electrocution. Fall prevention mats had furniture placed on top of them, defeating their protective purpose.
One resident's bed sensor alarm — designed to alert staff when someone stands up unassisted — was not functioning as ordered by physicians. The device is intended to prevent falls that could result in fractures or other injuries.
The insulin injection violations represent a fundamental breakdown in medication safety protocols that diabetes experts consider essential for preventing serious complications. When the same injection site is used repeatedly, patients can develop lipodystrophy, making insulin absorption unpredictable and blood sugar control more difficult.
The tissue damage can become permanent, limiting future injection sites and complicating diabetes management for years. In severe cases, the complications can contribute to poor blood sugar control that leads to hospitalization or other serious health consequences.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Mirage Post Acute from 2025-01-17 including all violations, facility responses, and corrective action plans.